73 related articles for article (PubMed ID: 28337474)
1. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.
Maza M; Alfaro K; Garai J; Velado MM; Gage JC; Castle PE; Felix J; Luciani S; Campos N; Kim J; Masch R; Cremer M
Gynecol Oncol Rep; 2017 May; 20():58-61. PubMed ID: 28337474
[TBL] [Abstract][Full Text] [Related]
2. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
3. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
[TBL] [Abstract][Full Text] [Related]
5. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program.
Alfaro KM; Gage JC; Rosenbaum AJ; Ditzian LR; Maza M; Scarinci IC; Miranda E; Villalta S; Felix JC; Castle PE; Cremer ML
BMC Public Health; 2015 Oct; 15():1058. PubMed ID: 26474762
[TBL] [Abstract][Full Text] [Related]
7. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
[TBL] [Abstract][Full Text] [Related]
8. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
9. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
11. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
13. Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future.
Alfaro K; Soler M; Maza M; Flores M; López L; Rauda JC; Chacón A; Erazo P; Villatoro N; Mumenthaler E; Masch R; Conzuelo G; Felix JC; Cremer M
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681756
[TBL] [Abstract][Full Text] [Related]
14. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
15. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Akakpo K; Aniakwa-Bonsu E; Amoako-Sakyi D; Jacques S; Mayaud P
Gynecol Oncol Res Pract; 2017; 4():5. PubMed ID: 28270915
[TBL] [Abstract][Full Text] [Related]
16. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
[TBL] [Abstract][Full Text] [Related]
17. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness analysis on the once-in-a-lifetime cervical cancer screening program for women living in rural and urban areas of China].
Xu H; Zhao FH; Gao XH; Hu SY; Chen JF; Liu ZH; Xu XL; Gao LM; Liu QG; Ma L; Liu YJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Apr; 34(4):399-403. PubMed ID: 23937850
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
